2seventy bio, Inc.

NASDAQ:TSVT

3.14 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -217.57-254.153-292.213-120.114-320.594-199.749
Depreciation & Amortization 10.28511.53316.3513.18812.58713.345
Deferred Income Tax 000000
Stock Based Compensation 32.15941.0454.62960.99762.04940.801
Change In Working Capital 2.604-35.87113.331-15.46935.144-3.818
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.4230.327-0.006-13.2414.6112.23
Other Working Capital 3.027-36.19813.337-2.22920.533-6.048
Other Non Cash Items 5.6640.3170.869-6.3952.8573.206
Operating Cash Flow -166.858-237.134-207.034-67.793-207.957-146.215
Investing Activities:
Investments In Property Plant And Equipment -13.865-22.842-19.575-22.261-59.765-50.827
Acquisitions Net 0-34.5390000
Purchases Of Investments -265.173-145.9080000
Sales Maturities Of Investments 322.899180.44734.986000
Other Investing Activites 034.539-32.997000
Investing Cash Flow 43.86111.69715.411-22.261-59.765-50.827
Financing Activities:
Debt Repayment 00000-1.017
Common Stock Issued 126.863165.5336.544000
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0.5270.696354.88990.054267.722198.059
Financing Cash Flow 127.39166.229354.88990.054267.722197.042
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 4.393-59.208163.266000
Cash At End Of Period 76.683104.058163.266000